Noted Cardiologist Discusses Studies Using CardioCell’s Therapy for Treating Chronic Heart Failure and Acute Myocardial Infarction
WASHINGTON, D.C. – STEM CELLS & REGENERATIVE MEDICINE CONGRESS 2015 – Sept. 1, 2015 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, announces a presentation by noted cardiologist Dr. Stephen Epstein, the company’s Scientific Advisory Board chair, as well as director, translational and vascular biology research at MedStar Heart Institute and clinical professor of medicine at Georgetown University. In the talk, “Stem Cell-Based Therapy in AMI and in HF Using Engraftment of MSCs Into Ischemic Myocardium,” Dr. Epstein offers new therapy concepts leveraging data derived from studies by CardioCell.
What:
Dr. Stephen Epstein presents “Stem Cell-Based Therapy in AMI and in HF Using Engraftment of MSCs Into Ischemic Myocardium”
When:
Thurs., Sept. 3, 2015, at 2:20 p.m. Eastern time
Where:
Stem Cells & Regenerative Medicine Congress 2015 Mandarin Oriental in Washington, D.C.
Contact:
Kimberly Stoddard, kimberly@townsendteam.com, (415) 806-5793
About CardioCell LLC
Founded in San Diego, California, in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique, patented, ischemia-tolerant mesenchymal stem cells manufactured under cGMP conditions. CardioCell is a subsidiary of Stemedica Cell Technologies Inc., a global biotechnology company that manufactures adult allogeneic stem cells. The company’s technology is based on more than 30 years of research and clinical experience conducted by scientists and physicians in the United States, Europe and the former Soviet Union. CardioCell therapies offer a unique, proprietary technology based on the expansion of cells in constant hypoxia, which provides critical benefits in terms of safety, efficacy and scalability. The company has an exclusive, worldwide license from Stemedica to explore therapeutic indications for unmet cardiovascular needs, such as acute myocardial infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD). For more information, visit www.stemcardiocell.com.
Help employers find you! Check out all the jobs and post your resume.
